Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Draftfcb Healthcare rebrands and acquires Halesway

The US agency will operate as FCB Health

- PMLiVE

Interview: Michel Pettigrew, Ferring

Ferring Pharmaceuticals' president on how the company encourages 'controlled entrepreneurship'

- PMLiVE

FDA scrutiny of alirocumab hits Regeneron and Sanofi

Regulator to assess neurocognitive effects of cholesterol drug

- PMLiVE

EMA to restrict use of domperidone and diacerein

Regulator's pharmacovigilance advisors also want insomnia drug zolpidem's labelling tightened up

- PMLiVE

New data puts Jakafi on course for blockbuster status

Novartis/Incyte drug meets targets in blood cancer trial

- PMLiVE

Oxford Pharmascience adds to board

John Goddard is former head of group strategic planning and business at AstraZeneca

NICE and ‘ultra orphans’

NICE and its processes for ‘highly specialised therapies’

- PMLiVE

UK to trial ingestible digital health technology

Proteus Digital Health will collaborate with several NHS bodies on the study

- PMLiVE

Death of a salesman

Will people communicate the same way if their results are not being measured?

- PMLiVE

Pfizer recalls depression drug in US

Wrong medicine found in bottle of Effexor XR

EU flag

J&J gets EU green light for novel TB drug

Sirturo approved to treat multidrug resistant form of the disease

Novartis building

Novartis’ dermatology plans advance with Xolair approval

Green light for use in chronic spontaneous urticaria

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links